Cargando…

Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic

In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Giacomo, Alfano, Gaetano, Fontana, Francesco, Magistroni, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542613/
https://www.ncbi.nlm.nih.gov/pubmed/33028570
http://dx.doi.org/10.1136/bcr-2020-236411
_version_ 1783591583375949824
author Mori, Giacomo
Alfano, Gaetano
Fontana, Francesco
Magistroni, Riccardo
author_facet Mori, Giacomo
Alfano, Gaetano
Fontana, Francesco
Magistroni, Riccardo
author_sort Mori, Giacomo
collection PubMed
description In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation was confirmed and he was thus transferred to the nephrology division. Physical examination and blood tests revealed a positive fluid balance and insufficient correction of the uraemic syndrome, although peritoneal dialysis prescription was maximised. After discussion with the patient and his family, the staff decided to start hybrid dialysis, consisting of once-weekly in-hospital haemodialysis and home peritoneal dialysis for the remaining days. He was discharged at the end of the antibiotic course, after an internal jugular vein central venous catheter placement and the first haemodialysis session. This strategy allowed improvement of depuration parameters and avoidance of frequent access to the hospital, which is crucial in limiting exposure to SARS-CoV-2 in an endemic setting.
format Online
Article
Text
id pubmed-7542613
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75426132020-10-19 Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic Mori, Giacomo Alfano, Gaetano Fontana, Francesco Magistroni, Riccardo BMJ Case Rep Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation was confirmed and he was thus transferred to the nephrology division. Physical examination and blood tests revealed a positive fluid balance and insufficient correction of the uraemic syndrome, although peritoneal dialysis prescription was maximised. After discussion with the patient and his family, the staff decided to start hybrid dialysis, consisting of once-weekly in-hospital haemodialysis and home peritoneal dialysis for the remaining days. He was discharged at the end of the antibiotic course, after an internal jugular vein central venous catheter placement and the first haemodialysis session. This strategy allowed improvement of depuration parameters and avoidance of frequent access to the hospital, which is crucial in limiting exposure to SARS-CoV-2 in an endemic setting. BMJ Publishing Group 2020-10-07 /pmc/articles/PMC7542613/ /pubmed/33028570 http://dx.doi.org/10.1136/bcr-2020-236411 Text en © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
spellingShingle Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Mori, Giacomo
Alfano, Gaetano
Fontana, Francesco
Magistroni, Riccardo
Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title_full Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title_fullStr Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title_full_unstemmed Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title_short Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
title_sort hybrid dialysis: a promising strategy to reduce hospital access during the sars-cov-2 pandemic
topic Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542613/
https://www.ncbi.nlm.nih.gov/pubmed/33028570
http://dx.doi.org/10.1136/bcr-2020-236411
work_keys_str_mv AT morigiacomo hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic
AT alfanogaetano hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic
AT fontanafrancesco hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic
AT magistroniriccardo hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic